Tag: Multiple Sclerosis
Whites Have Highest Prevalence of Multiple Sclerosis in the United States
Highest prevalence seen in those aged 45 to 64 years; prevalence also increased with each degree of latitude
AAN: Teriflunomide Reduces Clinical Events in Radiologically Isolated Syndrome
Significant reduction seen in clinical events with teriflunomide; nonsignificant reduction noted in Gd+ lesions, new or enlarging T2 lesions
Sleep Disorders Contribute to Cognitive Decline in Multiple Sclerosis
Insomnia, sleep apnea explain roughly 10 to 34 percent of the relationship between multiple sclerosis and cognitive dysfunction
MS Relapse Rate Not Increased After Fertility Treatments
Mean annualized relapse rate not different before versus after controlled ovarian stimulation
AAN: Mediterranean Diet Score Linked to Cognition in MS
Higher MEDAS score independently predicted lower risk for cognitive impairment; link stronger for those with progressive disease
Evidence Found of Causal Link for Multisite Chronic Pain and MS, RA
Association with multiple sclerosis and rheumatoid arthritis may be partially mediated by body mass index
Neighborhood Socioeconomic Status Tied to Mortality for Neurologic Conditions
Increased odds of 30-day mortality ranges from 2.46 to 1.23 for nontraumatic coma and stroke
Adolescent Sleep Patterns Tied to Later Multiple Sclerosis Risk
Sleeping less than seven hours per night and self-reported low sleep quality during adolescence associated with risk for developing MS
Aberrations Identified in Gut Microbiota of Multiple Sclerosis Patients
Cluster of inflammation markers positively associated with multiple sclerosis-related species
Autologous Hematopoietic Stem Cell Transplant Slows Disability Progression in MS
Slowing of disability progression and higher likelihood of disability improvement observed compared with standard disease-modifying therapies
